Posts
The Texas Biomedical Research
Institute (Texas Biomed) has applied for a patent for a genetically-engineered
vaccine for HIV prevention. The vaccine is designed to be administered in a
single dose that will last the patient a lifetime. It targets the outer layers
of the body structures that first come into contact with the virus. Officials
at Texas Biomed believe that the vaccine could be adapted for use against other
infections.
Marie-Claire Gauduin, PhD., of Texas
Biomed’s Department of Virology and Immunology is co-inventor on the patent
with Philippe Blancou, PhD., a visiting scientist from the University of
Nice-Sophia Antipolis in France. Gauduin stated that the development of an
effective AIDS vaccine that restricts viral replication at the mucosal level of
entry may be the best hope of controlling HIV. She added that only life-long
stimulation of the immune system by the vaccine will be sufficient to achieve
long-term protection.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!
